SUMMARY
Tetralogy of Fallot is comprised of a subaortic ventricular sepal defect, overriding aorta, and infundibular pulmonary stenosis. A severe form of this congenital heart defect is tetralogy of Fallot with pulmonary atresia (TOF/PA), characterized by absence of flow from the right ventricle to the pulmonary arteries. This is one of the most challenging and complex cardiac defects due to its many different anatomic variants. A novel method developed recently, known as Fetal Intelligent Navigation Echocardiography (FINE), allows automatic generation of nine standard fetal echocardiography views in normal hearts by applying “intelligent navigation” technology to spatiotemporal image correlation volume datasets. We report herein for the first time, two cases of TOF/PA with variable pulmonary arterial anatomy in which the FINE method successfully demonstrated the features of this condition prenatally.
Keywords: congenital heart disease, fetal heart, sonography, spatiotemporal image correlation, STIC, ultrasound
Clinical Cases
Case 1
A 31-year-old woman (G2, P0010) was referred to our research ultrasound unit at 30 weeks of gestation. Her past medical history was significant for childhood asthma and iron deficiency anemia. For both Cases presented herein, the women were examined at Detroit Medical Center/Wayne State University, and the Perinatology Research Branch of NICHD, NIH, DHHS. They were enrolled in a research protocol approved by the Institutional Review Board of NICHD, NIH, and by the Human Investigation Committee of Wayne State University. Both women provided written informed consent for the use of sonographic images for research purposes.
The patient had a body mass index (BMI) of 38.2, which is classified as severely obese.1 Four-dimensional (4D) sonography with spatiotemporal image correlation (STIC) was performed, in which multiple STIC volume datasets of the fetal heart containing gray-scale information were acquired from the apical four-chamber view by transverse sweeps through the fetal chest. The patient was asked to momentarily suspend breathing during STIC volume acquisition. The acquisition time was 12.5 seconds, while the acquisition angle was 35 degrees.
A single STIC volume dataset considered to be of highest quality was chosen for analysis by the FINE method.2 Since its original invention,2 FINE has been integrated into a commercially available ultrasound platform (UGEO WS80A; Samsung Healthcare, Seoul, Korea) and is known as 5D Heart technology. Using the Anatomic Box® feature, seven anatomical structures of the fetal heart were marked on the screen, which generates an internal geometrical model of the heart.2 The structures that were marked in sequential order are: 1) cross-section of the aorta at the level of the stomach; 2) cross-section of the aorta at the level of the four-chamber view; 3) crux; 4) right atrial wall; 5) pulmonary valve; 6) cross-section of the superior vena cava; and 7) transverse aortic arch. Once the marking process is completed, FINE allows automatic generation and display of nine standard fetal echocardiography views simultaneously in a single template: 1) four chamber; 2) five chamber; 3) left ventricular outflow tract; 4) short-axis view of great vessels/right ventricular outflow tract; 5) three-vessels and trachea (3VT); 6) abdomen/stomach; 7) ductal arch; 8) aortic arch; and 9) superior and inferior venae cavae.2 Such cardiac views in this template are known as diagnostic planes. Yet, the FINE method also includes a tool known as Virtual Intelligent Sonographer Assistance (VIS-Assistance®), which can be activated for each cardiac diagnostic plane.2–5 VIS-Assistance® allows operator-independent sonographic navigation and exploration of surrounding structures in the diagnostic plane (i.e. “virtual” sonographer) in the form of a videoclip, and therefore improves the quality of fetal cardiac examination. We have previously reported the value of VIS-Assistance® when congenital heart defects are present.2,6
Automatic labeling of the nine echocardiography views (i.e. diagnostic planes), anatomical structures, left and right sides of the fetus, and cranial and caudal ends is an additional and optional feature of the FINE method.2,3 Such labeling helps sonologists to recognize anatomical structures, especially when a cardiac defect is present.
Upon examination of the nine echocardiography views, we noted that five views were abnormal (Figure 1 and Videoclip 1). The 3VT view showed a severely hypoplastic pulmonary artery with dilated transverse aortic arch. The pulmonary valve appeared hyperechoic and closed throughout the cardiac cycle. As is typical, the four-chamber view appeared normal, and VIS-Assistance® demonstrated two pulmonary veins connecting normally to the left atrium. In the left ventricular outflow tract view, there was a subaortic ventricular septal defect (VSD) with overriding of the ventricular septum by the dilated aortic root. In addition, the aortic valve appeared thickened and dysplastic with “stiff” valvular excursion, suggesting aortic stenosis. The short-axis view of great vessels/right ventricular outflow tract showed pulmonary atresia with a severely hypoplastic pulmonary artery, as well as a tiny ductus arteriosus. In this view, the pulmonary valve tissue again appeared hyperechoic and closed throughout the cardiac cycle. The ductal arch demonstrated similar findings. In the aortic arch view, the aortic root was dilated and there was a prominent ascending aorta. It is noteworthy that automatic labeling of the cardiac anatomy was correct for all nine echocardiography views.
Figure 1: Application of the Fetal Intelligent Navigation Echocardiography (FINE) method to a spatiotemporal image correlation volume dataset of a fetus with tetralogy of Fallot and pulmonary atresia at 30 gestational weeks (Case 1).
(also see Videoclip 1). Diagnostic planes or Virtual Intelligent Sonographer Assistance (VIS-Assistance®) with automatic labeling are shown, in which five echocardiography views are abnormal. The three-vessels and trachea view shows a severely hypoplastic pulmonary artery with dilated transverse aortic arch. The pulmonary valve appears hyperechoic and closed throughout the cardiac cycle. The four-chamber view appears normal. VIS-Assistance® demonstrates two pulmonary veins connecting normally to the left atrium (not shown here). In the left ventricular outflow tract view, there is a subaortic ventricular septal defect with overriding of the ventricular septum by the dilated aortic root. In addition, the aortic valve appears thickened and dysplastic, suggesting aortic stenosis. The short-axis view of great vessels/right ventricular outflow tract view shows pulmonary atresia with a severely hypoplastic pulmonary artery, as well as a tiny ductus arteriosus. The pulmonary valve tissue again appears hyperechoic and closed throughout the cardiac cycle. The ductal arch view demonstrates similar findings. In the aortic arch view, the aortic root is dilated and there is a prominent ascending aorta. It is noteworthy that automatic labeling was correct for all nine echocardiography views. A, transverse aortic arch; Ao, aorta; Desc., descending; IVC, inferior vena cava; LA, left atrium; LV, left ventricle; P, pulmonary artery; PA, pulmonary artery; RA, right atrium; RV, right ventricle; RVOT, right ventricular outflow tract; S, superior vena cava; SVC, superior vena cava; Trans., transverse
In contrast, real-time fetal echocardiography performed during the same visit was very difficult and suboptimal because of the increased maternal BMI, as well as prominent shadowing from the fetal upper extremities, ribs, and sternum over the chest, that obscured the cardiac anatomy. Moreover, aortic stenosis was not apparent during the real-time cardiac sonographic examination. Yet, there was an opportune moment in which STIC volume datasets without shadowing artifacts could be successfully obtained in a short period of time.
The fetus was appropriately grown for gestational age, and the amniotic fluid volume was normal. The patient was offered non-invasive prenatal testing, as well as amniocentesis and fluorescent in-situ hybridization (FISH) for 22q11.2 deletion syndrome, but she declined all testing. Serial ultrasound examinations for fetal growth were performed during the pregnancy and were within normal limits.
Delivery and Postnatal course
At 38 5/7 weeks of gestation, the patient underwent a spontaneous vaginal delivery and delivered a viable female neonate weighing 2930 grams. Apgar scores were 8 and 9 (at 1 and 5 minutes, respectively). Genetic testing for 22q11.2 deletion syndrome was negative. Postnatal transthoracic echocardiography on day one of life confirmed the diagnosis of TOF/PA with a large perimembranous VSD and overriding aorta (Figure 2A). The aortic valve leaflets appeared dysplastic, with narrowing seen in the supravalvar area. Spectral Doppler interrogation revealed a moderate degree of stenosis across the aortic valve and supravalvar region, with color Doppler aliasing seen from the turbulent flow across this area (Figure 2B and Videoclip 2). In addition, echocardiography demonstrated the presence of multiple sources of blood supply to the lungs from the aorta, including what appeared to be a small patent ductus arteriosus (PDA) giving rise to severely hypoplastic native pulmonary arteries. The neonate was placed on continuous prostaglandin E1 infusion to maintain ductal patency.
Figure 2: Case 1 neonate.
A: Transthoracic echocardiogram of the parasternal long-axis view at day one of life. A large perimembranous ventricular septal defect and overriding aorta is seen. The aortic valve leaflets are also thickened and dysplastic (white arrow), with narrowing of the supravalvar area (yellow arrow). The atretic pulmonary valve is not seen in this plane. Asc Ao, ascending aorta; LV, left ventricle; RV, right ventricle; VSD, ventricular septal defect.
B: Transthoracic echocardiogram of the apical four-chamber view at day one of life. Color Doppler flow is seen exiting both ventricles through the ventricular septal defect into the overriding aorta. Color Doppler aliasing is present (white arrow) due to turbulent flow across the aortic valve and supravalvar area. The ascending aorta past the level of the aortic valve is not visualized in this image. Note that the color Doppler bar orientation does not correspond to the orientation of blood flow depicted in the heart, because the image has been flipped for illustrative purposes. LV, left ventricle; RV, right ventricle; VSD, ventricular septal defect.
C: Cardiac catheterization at day five of life. Right upper pulmonary vein wedge angiogram shows contrast filling the upper lobe of the right lung (white star). Contrast then travels retrograde into the native pulmonary arteries, demonstrating the presence of confluent, but severely hypoplastic native pulmonary arteries (white arrows) supplied by a small patent ductus arteriosus (yellow arrow) to perfuse both the right and left lungs. These native pulmonary arteries (although severely hypoplastic) appear to provide almost complete blood supply to the lung fields. An additional major collateral artery (not seen in this image) was seen originating from an anomalous right subclavian artery to provide dual blood supply to the right lung. PDA, patent ductus arteriosus.
Cardiac catheterization on day five of life confirmed the diagnosis and further delineated the distribution of pulmonary blood flow. Angiography demonstrated the presence of severely hypoplastic native confluent pulmonary arteries supplied by a small PDA (with preferential supply to the left lung) (Figure 2C). Additionally, there was a major aorto-pulmonary collateral artery (MAPCA) arising from an anomalous right subclavian artery to perfuse the right lung (not shown in Figure 2C). Despite the severe degree of pulmonary artery hypoplasia, initial attempts at surgical repair were undertaken by performing pulmonary arterial unifocalization and Blalock-Taussig shunt placement, along with relief of the supravalvar aortic stenosis. However, the neonate expired after a relatively short post-operative course due to persistent hypoxemia and hemodynamic compromise. An autopsy was not performed.
Case 2
A 28-year old woman (G3, P2002) was referred to our research ultrasound unit at 22 weeks of gestation. Her past medical history was significant for pseudotumor cerebri, asthma, chronic hypertension, iron deficiency anemia, and seizure disorder. In addition, her grandfather had an unspecified heart defect as a child that required surgery. The patient had a BMI of 33, which is classified as obese.1 Earlier on the same day, she underwent a clinical ultrasound examination in which a cardiac defect was suspected, but the specific diagnosis could not be determined. We performed 4D sonography with STIC, in which volume datasets of the fetal heart containing gray-scale and color Doppler information were acquired from the apical four-chamber view by transverse sweeps through the fetal chest. The patient was asked to momentarily suspend breathing during the STIC volume acquisitions. The acquisition time was 10 seconds, while the acquisition angle was 30 degrees. Two STIC volume datasets (gray-scale and color Doppler each) considered to be of highest quality were chosen for analysis by the FINE method.2
For this case, it is noteworthy that when attempting to mark the pulmonary valve using Anatomic Box® in the gray-scale STIC volume, a clear valve could not be identified. Yet, it was still possible to estimate the location for marking due to two technologic features of FINE: 1) pulmonary valve alert,5,7 which was automatically activated during the marking process because the fetal spine in the STIC volume was located between 4- and 5-o’clock; and 2) intelligent cursor placement. The pulmonary valve alert is a type of marking alert (i.e. movie) which notifies the sonologist that fetal anatomical structures for marking (e.g. pulmonary valve) may be in different locations than what is expected.5,7 Such movie depicts a reference image example to guide and teach the sonologist how to mark the anatomic structure of interest. Another feature of FINE which simplifies the marking process for the user is “intelligent” cursor placement, in which the system automatically places the cursor near, or at the location to be marked. Intelligent cursor placement occurs for four anatomic structures (right atrial wall, pulmonary valve, superior vena cava, and transverse aortic arch).
For the gray-scale STIC volume, six echocardiography views were abnormal (Figure 3A and Videoclip 3). The 3VT view showed a large transverse aortic arch without a pulmonary artery identified. The four-chamber view appeared normal. However, when VIS-Assistance® was activated, a VSD with overriding aorta became visible. In the five-chamber view, the anteriorly malaligned VSD was visualized with overriding of the ventricular septum by the dilated aortic root. The left ventricular outflow tract view showed similar findings. Movement of the aortic valve leaflets in this fetus appeared normal. In the short-axis view of great vessels/right ventricular outflow tract, the main pulmonary artery and valve, branch pulmonary arteries, and ductus arteriosus could not be identified. Similarly in the ductal arch view, the main pulmonary artery and valve, as well as the ductus arteriosus could not be visualized. The aortic arch view showed a dilated aortic root and a prominent ascending aorta. Importantly, automatic labeling of the cardiac anatomy was correct for all nine echocardiography views. Moreover, labeling of the pulmonary artery by FINE (Figure 3A and Videoclip 3) was in the “appropriate” location, even though an actual main pulmonary artery and valve could not be visualized. When the color Doppler STIC volume was analysed by FINE,6 multiple echocardiography views demonstrated color flow in the aorta, but absent flow in the area of the main pulmonary artery, confirming the diagnosis of pulmonary atresia.
Figure 3: Case 2 with tetralogy of Fallot and pulmonary atresia.
A: Application of the Fetal Intelligent Navigation Echocardiography (FINE) method to a spatiotemporal image correlation volume dataset of the fetus at 22 gestational weeks (also see Videoclip 3). Diagnostic planes or Virtual Intelligent Sonographer Assistance (VIS-Assistance®) with automatic labeling are shown, in which six echocardiography views are abnormal. The three-vessels and trachea view shows a large transverse aortic arch without a pulmonary artery identified. The four-chamber view appears normal. However, when VIS-Assistance® is activated, a ventricular septal defect with overriding aorta became visible (not shown here). In the five-chamber view, the anteriorly malaligned ventricular septal defect is visualized with overriding of the ventricular septum by the dilated aortic root. The left ventricular outflow tract view shows similar findings. Movement of the aortic valve leaflets is normal. In the short-axis view of great vessels/right ventricular outflow tract view, the main pulmonary artery and valve, branch pulmonary arteries, and ductus arteriosus cannot be identified. Similarly in the ductal arch view, the main pulmonary artery and valve, as well as the ductus arteriosus cannot be visualized. The aortic arch view shows a dilated aortic root and a prominent ascending aorta. It is noteworthy that automatic labeling was correct for all nine echocardiography views. Labeling of the pulmonary artery by FINE is in the “appropriate” location, even though an actual main pulmonary artery and valve cannot be visualized. A, transverse aortic arch; Ao, aorta; Desc., descending; IVC, inferior vena cava; LA, left atrium; LV, left ventricle; P, pulmonary artery; PA, pulmonary artery; RA, right atrium; RV, right ventricle; RVOT, right ventricular outflow tract; S, superior vena cava; SVC, superior vena cava; Trans., transverse
B: Spatiotemporal image correlation volume dataset acquired with color Doppler imaging at 30 gestational weeks and analysed by color Doppler Fetal Intelligent Navigation Echocardiography (FINE). In the left ventricular outflow tract view, there is a color signal (blue) exiting from both ventricles into the overriding aorta. Automatic labeling by FINE (left ventricle, and name of echocardiography view) is depicted. LV, left ventricle.
The patient underwent second trimester amniocentesis and the karyotype was 46XY. Microarray studies were normal, including testing for 22q11.2 deletion syndrome. At 30 weeks of gestation, a STIC volume dataset was obtained with color Doppler information and FINE demonstrated color flow exiting both ventricles into the large overriding aorta (Figure 3B). The fetus was appropriately grown for gestational age and the amniotic fluid volume was normal.
Delivery and Postnatal course
At 39 5/7 weeks of gestation, the patient underwent induction of labor due to anhydramnios and delivered a viable male infant weighing 3530 grams vaginally. The Apgar scores were 8 and 9 (at 1 and 5 minutes, respectively). Given the known prenatal diagnosis of pulmonary atresia, the neonate was started on continuous prostaglandin E1 infusion shortly after birth and was clinically well with acceptable saturations. The postnatal echocardiogram at day one of life confirmed the diagnosis of TOF/PA, with a large anterior malaligned VSD and overriding aorta (Figure 4A and4B). Although the initial postnatal echocardiogram suggested a ductus arteriosus supplying confluent pulmonary arteries, subsequent studies determined the presence of discontinuous pulmonary arteries (Figure 5A and5B) with bilateral large MAPCAs – each providing complete blood supply to its respective lung.
Figure 4: Transthoracic echocardiogram of the parasternal long-axis view at day one of life (Case 2).
A: Gray scale image shows a large anterior malaligned ventricular septal defect and overriding aorta.
B: Color Doppler imaging demonstrates blood flow exiting both ventricles (blue color signal) into the large overriding ascending aorta. LA, left atrium; LV, left ventricle; RV, right ventricle; VSD, ventricular septal defect.
Figure 5: Transthoracic echocardiography from the suprasternal notch at day one of life (Case 2).
A: Major aortopulmonary collateral (MAPCA) originating from the proximal brachiocephalic artery (white arrow) to form the right pulmonary artery distally, coursing to the neonate’s right side to supply the right lung.
B: Another large MAPCA originates from the underside of the aortic arch and courses to the neonate’s left side to form the left pulmonary artery and supply the left lung. The mid-portion of the right pulmonary artery is also visualized in this image. Asc Ao, ascending aorta; LPA, left pulmonary
Cardiac catheterization obtained in the first few days of life confirmed a non- confluent pulmonary arterial system. Angiographic imaging showed a major systemic-to-pulmonary collateral artery (i.e. MAPCA) originating from the right innominate artery to supply the entire right lung, and an additional large MAPCA arising from the underside of the aortic arch to supply the entire left lung (Figure 6A and6B). Given the overall normally-sized pulmonary arteries, early surgical correction was performed on day 5 of life, consisting of VSD closure, unifocalization of the pulmonary arteries, and placement of a right ventricle-to-pulmonary artery conduit. The neonate was discharged home in good clinical condition after an uneventful postoperative course. At the time of this writing (13 months of age), the right ventricular systolic function was normal and the neonate was doing well overall, except for some intermittent complaints of mild exercise intolerance.
Figure 6: Cardiac catheterization at day two of life (Case 2).
A: Anterior-posterior view. Angiography in the proximal descending aorta demonstrates a right-sided MAPCA originating from the proximal portion of the right innominate artery (yellow arrow) to supply the entire normally-sized right pulmonary artery.
B: Left anterior oblique view. The left pulmonary artery originates as a large MAPCA from the underside of the aortic arch. No collaterals are seen from the descending aorta. The aortic arch is left-sided with a normal brachiocephalic branching pattern (entire arch is not fully shown in this image). The right pulmonary artery is seen faintly due to the location of contrast injection remote from its origin. Desc Ao, descending aorta; LCCA, left common carotid artery; LPA, left pulmonary
Discussion
FINE as a method to diagnose congenital heart disease
We report herein for the first time, two different cases of TOF/PA with variable sources of pulmonary blood flow in which the diagnosis was made successfully using the FINE method. This is relevant because of the complex and heterogeneous nature of this cardiac defect. In addition, supravalvar aortic stenosis was evident for Case 1 using FINE, but was not the case on real-time fetal echocardiography.
FINE is a novel method which automatically generates and displays nine standard fetal echocardiography views in normal hearts by applying “intelligent navigation” technology to STIC volume datasets.2–6 As a result, such method considerably simplifies examination of the fetal heart and reduces operator dependency.2 When FINE was first developed, we proposed using this technology to examine the fetal heart in the population at large, instead of diagnosing congenital heart disease.2 However, since that time our group has reported that FINE: 1) demonstrates abnormal fetal cardiac anatomy successfully;2,6–9 and 2) has high accuracy (95%) in detecting a broad spectrum of congenital heart disease.7 Moreover, we have recently shown that the implementation of color Doppler FINE successfully demonstrates abnormal fetal cardiac anatomy and hemodynamic flow in cases of cardiac anomalies.6 For Case 2, color Doppler FINE was especially helpful, because it confirmed the absence of pulmonary blood flow and the presence of antegrade color flow into the overriding aorta for multiple echocardiography views.
For both cases herein, there were several specific features of the FINE method that were very helpful in making the prenatal diagnosis of TOF/PA: 1) VIS-Assistance®; and 2) automatic labeling. VIS-Assistance® allowed automatic navigation and exploration of each cardiac diagnostic plane, thus confirming a severely hypoplastic pulmonary artery with closed pulmonary valve (Case 1), as well as non-visualization of the main pulmonary artery and valve, branch pulmonary arteries, and ductus arteriosus (Case 2). It is noteworthy that automatic labeling (anatomical structures, diagnostic planes, left and right sides of the fetus, and cranial and caudal ends) was correct in all nine fetal echocardiography views for both cases. This is possible because the system “infers” the actual location of structures in space.3
Tetralogy of Fallot with pulmonary atresia: variable anatomy of the pulmonary arterial circulation
TOF/PA (also known as pulmonary atresia with VSD) comprises approximately 20% of all TOF cases.10 It is a rare form of congenital heart disease (10/100,000 live born infants),11 and is characterized by atresia of the pulmonary valve, pulmonary artery hypoplasia, VSD, and an overriding aorta. The aortic root often has a greater diameter than that seen in TOF, because all of the right ventricular stroke volume exits into the overriding aorta. Pulmonary atresia can vary from complete muscular separation between the right ventricular outflow tract and pulmonary trunk, to separation of these two structures by an imperforate pulmonary valve.12 The pulmonary trunk itself may be patent up to the level of an imperforate valve, can originate blindly above an area of muscular atresia (Figure 7), or can be thread-like throughout its length.12 In other cases, the pulmonary trunk may be completely absent, along with the intrapericardial pulmonary arteries. As a consequence, patients with TOF/PA are dependent on a PDA or systemic aortopulmonary collateral arteries for pulmonary blood flow. The two cases reported herein demonstrate the heterogeneity of this cardiac defect – specifically, the presence or absence of native confluent pulmonary arteries (Cases 1 and 2, respectively), as well as varied sources of pulmonary blood flow in the form of a PDA or MAPCAs. The clinical presentation of neonates depends upon the amount and source of pulmonary blood flow. Specifically, the severity of cyanosis relates to the progressive narrowing and closure of the ductus arteriosus, and adequacy of the systemic-to-pulmonary collateral vessels.12
Figure 7: Pathologic specimen of a different neonate with tetralogy of Fallot and pulmonary atresia.

A metal probe is seen through the large, perimembranous ventricular septal defect. The aorta (opened through a vertical incision) is dilated and overrides the ventricular septal defect. The right ventricle is hypertrophied (black star) and there is muscular pulmonary atresia (no true connection) (red stars). The native main pulmonary artery is present but severely hypoplastic, measuring 1.5 mm (white arrow) and connected to the aorta by the ductus arteriosus (white star). The lungs are seen in the background. RV, right ventricle.
The differential diagnosis includes TOF, common arterial trunk (or truncus arteriosus), double outlet right ventricle with pulmonary stenosis or atresia, and single ventricle with pulmonary stenosis or atresia. Yet, features which distinguish TOF/PA from classic TOF include an absent right ventricular outflow tract and severe abnormalities in the pulmonary circulation, in which the pulmonary blood supply may be entirely from the systemic arterial circulation. Since the four-chamber view typically appears normal on ultrasound, TOF/PA is unlikely to be recognized during fetal cardiac screening if the outflow tracts are not evaluated.
Although TOF/PA can be diagnosed in the prenatal period,13–17 it can be difficult to determine the morphology of the central pulmonary arteries (i.e. size and anatomy) and locate the source of pulmonary blood supply.16 Indeed, Volpe et al. reported that two-dimensional and color Doppler echocardiography failed to assess the anatomy of the central pulmonary arteries and source of pulmonary blood supply in 33% and 25% of 12 fetuses, respectively.14 On the other hand, the authors reported that the combination of STIC and B-flow imaging (which uses digitally encoded sonographic technology to provide direct visualization of blood echoes in gray scale) successfully did so for a different set of five fetuses.14 Since TOF/PA is often a ductal-dependent cardiac defect, the fetus should ideally be born at a center in which prostaglandins can be administered immediately after birth.
Once TOF/PA has been diagnosed prenatally, both the counseling and prognosis are influenced mainly by the morphology of the central pulmonary arteries and sources of pulmonary blood supply, as well as the presence of genetic and extracardiac abnormalities.14,16 The main source of variability among patients is the anatomy of the pulmonary arteries, ranging from well-formed and confluent pulmonary artery branches to completely absent pulmonary arteries. Sources of pulmonary blood flow may be from the ductus arteriosus, systemic-pulmonary collateral circulation, or a combination of both,14,18 as seen in the first case. Typically, when the pulmonary arterial supply is derived from the ductus arteriosus, the intrapericardial pulmonary arteries are confluent.12,18 However, the solitary ductus may be right or left-sided, and bilateral ducti can supply non-confluent pulmonary arteries with a normal distribution.12
Collateral arteries from the descending aorta to the lungs (i.e. MAPCAs) represent remnants of the embryonic ventral splanchnic arteries and normally regress when the normal pulmonary arterial system forms early in gestation.19 However, major collateral arteries may persist when there is early maldevelopment of the pulmonary valve or central pulmonary arterial system, as in TOF/PA.19 MAPCAs are present in 20–25% of patients with TOF/PA,20,21 and may be identified prenatally in 44% of cases.16 Gomez et al. reported that of their fetuses with TOF/PA, MAPCAs were present in 50%.13 Yet, the prenatal identification of MAPCAs is challenging, since they can vary greatly in size, number (usually two to six), site of origin (e.g. ascending aorta, descending aorta, head and neck vessels, coronary arteries), structure, and course within the mediastinum.17 Moreover, as MAPCAs have a serpiginous course, they may not be visualized in a single plane. Identification of such arteries in the prenatal period is enhanced by color Doppler imaging with low velocity settings, as well as pulsed Doppler velocimetry.17 For Case 2, color Doppler FINE (in which a high velocity scale was used for STIC volume acquisition) did not demonstrate evidence of MAPCAs. In the postnatal period, echocardiography is typically followed by diagnostic cardiac catheterization (considered the gold standard) to delineate the number of MAPCAs, their diameter, origin, course, and supplied lung lobes.22,23 Such information is important for surgical planning and repair, as well as prognosis.
A classification system for TOF/PA has been suggested by the Society of Thoracic Surgeons and is based on where the pulmonary arterial flow is derived from:24 1) Type A: native intrapericardial pulmonary arteries exclusively; 2) Type B: both native intrapericardial pulmonary arteries and MAPCAs (Case 1); and 3) Type C: MAPCAs exclusively (Case 2).
Patients with relatively normal-sized confluent central pulmonary arteries usually receive pulmonary blood flow from the ductus arteriosus, rarely have incomplete distribution of the right and left pulmonary arteries, and rarely have significant MAPCAs.16,25 The majority of TOF/PA cases have confluent native pulmonary arteries (Case 1), but they are hypoplastic; flow into them is derived from MAPCAs, usually through small intrapulmonary communications.27 More than 80% of those with non-confluent or hypoplastic central pulmonary arteries have incomplete distribution of one or both pulmonary arteries, with MAPCAs supplying the non-connected pulmonary arterial segments.16,26 Non-confluent or severely hypoplastic central pulmonary arteries and an extensive collateral aortopulmonary arterial circulation have a major impact on surgical treatment and can substantially increase risk.16 Less commonly, the native central pulmonary arteries are completely absent, and all pulmonary blood flow is derived from MAPCAs,27 as seen in Case 2.
Associated findings, prognosis, and outcome
In 20–50% of TOF/PA cases, there is a right-sided aortic arch.28 Moreover, the presence of MAPCAs is significantly associated with a right aortic arch.13 A secundum atrial septal defect or patent foramen ovale is seen in approximately 50% of cases postnatally.28 In addition, an absent ductus arteriosus may be seen in about half of all cases.29
Chromosomal abnormalities have been reported in 8.3% of children with TOF/PA.10 Moreover, there is an important association of this cardiac defect with deletions in the chromosomal region 22q11. Indeed, the prevalence of 22q11.2 deletion is found in 26% of fetuses with TOF/PA.16 The 22q11 microdeletion is more common in cases of TOF/PA with major collateral arteries when compared to tetralogy of Fallot with pulmonary stenosis.19 Some investigators have also reported that for fetal TOF/PA, the incidence of 22q11.2 deletion is higher in the subgroup with MAPCAs (50%) than in the subgroup without MAPCAs (10%), although this did not reach statistical significance.13 The interstitial deletion 16q21-q22.1 has also been reported in a newborn with TOF/PA, MAPCAs, dysmorphic craniofacial features, failure to thrive, and severe psychomotor developmental delay.30 Taken together, prenatal testing should be offered to all women carrying a fetus with TOF/PA.
The prognosis and long-term survival of TOF/PA primarily depend upon the underlying distribution and size of the pulmonary arteries, as well as any associated abnormalities. In general, if the ductus arteriosus is the primary source of pulmonary flow, long-term outcome is improved.29 In addition, patients without intrapericardial pulmonary arteries but with confluent intrapulmonary arteries have a better outcome than those with nonconfluent pulmonary arteries.19
The surgical management of patients with TOF/PA and MAPCAs includes establishing antegrade pulmonary blood flow via a conduit from the right ventricle to the pulmonary arteries, and unifocalization of the aortopulmonary collateral vessels to the pulmonary arteries22,31 (as in Case 2). In some cases, a complete repair cannot be performed, and staged unifocalization is required, with the goal of recruiting as many lung segments as possible (Case 1). Unifocalization broadly refers to procedures that join the multifocal sources of arterial supply (whether intrapericardial arteries or collateral arteries) into a single source that has a uniform flow and pressure for each bronchopulmonary segment.12,19 In general, however, the surgical approach to accomplish the goals described above is quite variable, depending on the individual anatomy of each neonate, and frequently requires more than one surgical procedure.19,22,23,32 For example, in cases of severely hypoplastic pulmonary arteries, a staged approach is preferred to allow pulmonary arterial growth.33 An issue that is controversial is the timing, if ever, of VSD closure.32 The final goal of surgery is to construct completely separated pulmonary and systemic circulations. In addition, preserving perfusion to as many lung segments as possible and avoiding irreversible changes in the pulmonary vascular bed is desired.27
Cho et al. reported that of 160 patients with TOF/PA who did not undergo complete surgical repair, the early and late mortality were 16.3% and 23.1%, respectively.34 The presence of MAPCAs was a significant risk factor of late mortality. However, for the 335 patients who did undergo complete surgical repair, the early and late mortality was 4.5%.34
Despite advances in the surgical and interventional treatment of TOF/PA, inadequate growth of the pulmonary vasculature is still apparent in a fraction of patients even after optimal treatment.19 Further discussion about the surgical treatment of TOF/PA is beyond the scope of this article, and the interested reader is referred to the scientific literature on this subject.
Conclusion
TOF/PA is a complex and heterogeneous cardiac defect with many anatomic variants, especially in the pulmonary arterial circulation. We report herein for the first time, two cases of TOF/PA with variable pulmonary arterial anatomy in which the FINE method successfully demonstrated the features of this cardiac abnormality in the prenatal period.
Supplementary Material
Acknowledgments
An application for a patent (“Apparatus and Method for Fetal Intelligent Navigation Echocardiography”) has been filed with the U.S. Patent and Trademark Office, and the patent is pending. Dr. Lami Yeo and Dr. Roberto Romero are co-inventors, along with Mr. Gustavo Abella and Mr. Ricardo Gayoso. The rights of Dr. Yeo and Dr. Romero have been assigned to Wayne State University, and NICHD/NIH, respectively.
The work of Dr. Romero was supported by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. Dr. Romero has contributed to this work as part of his official duties as employee of the United States Federal Government. Dr. Lami Yeo was funded by Wayne State University through a service contract in support of the Perinatology Research Branch.
This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C.
References
- 1.Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med 2017; 5:161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yeo L, Romero R. Fetal Intelligent Navigation Echocardiography (FINE): a novel method for rapid, simple, and automatic examination of the fetal heart: Ultrasound Obstet Gynecol 2013; 42:268–284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yeo L, Romero R. Intelligent navigation to improve obstetrical sonography. Ultrasound Obstet Gynecol 2016; 47:403–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Garcia M, Yeo L, Romero R, et al. Prospective evaluation of the fetal heart using Fetal Intelligent Navigation Echocardiography (FINE). Ultrasound Obstet Gynecol 2016; 47:450–459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Veronese P, Bogana G, Cerutti A, Yeo L, Romero R, Gervasi MT. A prospective study of the use of Fetal Intelligent Navigation Echocardiography (FINE) to obtain standard fetal echocardiography views. Fetal Diagn Ther 2017; 41:89–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yeo L, Romero R. Color and power Doppler combined with Fetal Intelligent Navigation Echocardiography (FINE) to evaluate the fetal heart. Ultrasound Obstet Gynecol 2017; 50:476–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Yeo L, Luewan S, Romero R. Fetal Intelligent Navigation Echocardiography (FINE) detects congenital heart disease with a sensitivity of 98%, specificity of 93% and accuracy of 95% [abstract]. Ultrasound Obstet Gynecol 2017; 50 (Suppl. 1):100.27420402 [Google Scholar]
- 8.Yeo L, Luewan S, Markush D, Gill N, Romero R. Prenatal diagnosis of dextrocardia with complex congenital heart disease using Fetal Intelligent Navigation Echocardiography (FINE) and a literature review [published online ahead of print June 23, 2017]. Fetal Diagn Ther. doi: 10.1159/000468929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Yeo L, Romero R. Prenatal diagnosis of hypoplastic left heart and coarctation of the aorta with color Doppler FINE. Ultrasound Obstet Gynecol 2017; 50:543–544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ferencz C Epidemiology of congenital heart disease: the Baltimore-Washington infant study, 1981–1989 (Perspectives in pediatric cardiology). Futura Publishing Company; 1993. [Google Scholar]
- 11.Leonard H, Derrick G, O’Sullivan J, Wren C. Natural and unnatural history of pulmonary atresia. Heart 2000; 84:499–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rossi RN, Hislop A, Anderson RH, Martins FM, Cook AC. Systemic-to-pulmonary blood supply in Tetralogy of Fallot with pulmonary atresia. Cardiol Young 2002; 12:373–388. [DOI] [PubMed] [Google Scholar]
- 13.Gómez O, Soveral I, Bennasar M, et al. Accuracy of fetal echocardiography in the differential diagnosis between truncus arteriosus and pulmonary atresia with ventricular septal defect. Fetal Diagn Ther 2016; 39:90–99. [DOI] [PubMed] [Google Scholar]
- 14.Volpe P, Campobasso G, Stanziano A, et al. Novel application of 4D sonography with B-flow imaging and spatio-temporal image correlation (STIC) in the assessment of the anatomy of pulmonary arteries in fetuses with pulmonary atresia and ventricular septal defect. Ultrasound Obstet Gynecol 2006; 28:40–46. [DOI] [PubMed] [Google Scholar]
- 15.Seale AN, Ho SY, Shinebourne EA, Carvalho JS. Prenatal identification of the pulmonary arterial supply in tetralogy of Fallot with pulmonary atresia. Cardiol Young 2009; 19:185–191. [DOI] [PubMed] [Google Scholar]
- 16.Vesel S, Rollings S, Jones A, Callaghan N, Simpson J, Sharland GK. Prenatally diagnosed pulmonary atresia with ventricular septal defect: echocardiography, genetics, associated anomalies and outcome. Heart 2006; 92:1501–1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Miyashita S, Chiba Y. Prenatal demonstration of major aortopulmonary collateral arteries with tetralogy of Fallot and pulmonary atresia. Fetal Diagn Ther 2004; 19:100–105. [DOI] [PubMed] [Google Scholar]
- 18.Liao PK, Edwards WD, Julsrud PR, Puga FJ, Danielson GK, Feldt RH. Pulmonary blood supply in patients with pulmonary atresia and ventricular septal defect. J Am Coll Cardiol 1985; 6:1343–1350. [DOI] [PubMed] [Google Scholar]
- 19.Boshoff D, Gewillig M. A review of the options for treatment of major aortopulmonary collateral arteries in the setting of tetralogy of Fallot with pulmonary atresia. Cardiol Young 2006; 16:212–220. [DOI] [PubMed] [Google Scholar]
- 20.Rabinovitch M, Herrera-deLeon V, Castaneda AR, Reid L. Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation 1981; 64:1234–1249. [DOI] [PubMed] [Google Scholar]
- 21.Jefferson K, Rees S, Somerville J. Systemic arterial supply to the lungs in pulmonary atresia and its relation to pulmonary artery development. Br Heart J 1972; 34:418–427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Meinel FG, Huda W, Schoepf UJ, et al. Diagnostic accuracy of CT angiography in infants with tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. J Cardiovasc Comput Tomogr 2013; 7:367–375. [DOI] [PubMed] [Google Scholar]
- 23.Brawn WJ, Jones T, Davies B, Barron D. How we manage patients with major aorta pulmonary collaterals. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009:152–7. [DOI] [PubMed] [Google Scholar]
- 24.Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project: pulmonary atresia--ventricular septal defect. Ann Thorac Surg 2000; 69:S97–105. [DOI] [PubMed] [Google Scholar]
- 25.Haworth SG, Macartney FJ. Growth and development of pulmonary circulation in pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Br Heart J 1980; 44:14–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Shimazaki Y, Maehara T, Blackstone EH, Kirklin JW, Bargeron LM Jr. The structure of the pulmonary circulation in tetralogy of Fallot with pulmonary atresia. A quantitative cineangiographic study. J Thorac Cardiovasc Surg 1988; 95:1048–1058. [PubMed] [Google Scholar]
- 27.Prieto L Management of tetralogy of fallot with pulmonary atresia. Images Paediatr Cardiol 2005; 7:24–42. [PMC free article] [PubMed] [Google Scholar]
- 28.Bharati S, Paul MH, Idriss FS, Potkin RT, Lev M. The surgical anatomy of pulmonary atresia with ventricular septal defect: pseudotruncus. J Thorac Cardiovasc Surg 1975; 69:713–721. [PubMed] [Google Scholar]
- 29.Abuhamad A, Chaoui R. Tetralogy of Fallot, pulmonary atresia with ventricular septal defect, and absent pulmonary valve syndrome In: Abuhamad A, Chaoui R (eds).A Practical Guide to Fetal Echocardiography: Normal and Abnormal Hearts. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2016: 396–421. [Google Scholar]
- 30.Yamamoto T, Dowa Y, Ueda H, et al. Tetralogy of Fallot associated with pulmonary atresia and major aortopulmonary collateral arteries in a patient with interstitial deletion of 16q21-q22.1. Am J Med Genet A 2008; 146A:1575–1580. [DOI] [PubMed] [Google Scholar]
- 31.Grant EK, Berger JT. Use of pulmonary hypertension medications in patients with tetralogy of Fallot with pulmonary atresia and multiple aortopulmonary collaterals. Pediatr Cardiol 2016; 37:304–312. [DOI] [PubMed] [Google Scholar]
- 32.Farouk A, Zahka K, Siwik E, et al. Individualized approach to the surgical treatment of tetralogy of Fallot with pulmonary atresia. Cardiol Young 2009; 19:76–85. [DOI] [PubMed] [Google Scholar]
- 33.Marshall AC, Love BA, Lang P, et al. Staged repair of tetralogy of Fallot and diminutive pulmonary arteries with a fenestrated ventricular septal defect patch. J Thorac Cardiovasc Surg 2003; 126:1427–1433. [DOI] [PubMed] [Google Scholar]
- 34.Cho JM, Puga FJ, Danielson GK, et al. Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg 2002; 124:70–81. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.









